1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Albany International's Italian affiliate will begin consultations with employee representatives on a plan to discontinue manufacturing at a leased facility in Ballo, Italy, and move production to a Merone, Italy facility owned by another Albany affiliate. The company says the move aims to rationalize costs and align engineered fabrics capacity with local demand, but it cannot yet estimate the costs and will disclose them once determined.
Affiliate Albany International Italia Srl will consult employee representatives before implementing the plan, as required by local law.
The Ballo, Italy leased facility would be closed and production transferred to Merone, Italy.
Impacted employees will be offered transfer opportunities or separation and outplacement assistance.
The company has not estimated the costs and says it will disclose the amount, type and timing once determined.
Owens Corning agreed on February 13, 2025 to sell materially all of its global glass reinforcements business to buyers affiliated with the Praana Group at an enterprise value of $755 million, including $68 million of net metal lease liabilities, with completion expected in 2025. The company expects to record an impairment charge but says it cannot yet estimate the amount, and the Composites segment will be eliminated, which matters to shareholders because the size of the charge and the reporting changes are still unclear.
Enterprise value of $755 million, including $68 million of net metal lease liabilities; completion expected in 2025, subject to regulatory approvals and consents.
Expected after-tax net proceeds of about $360 million, including $225 million of promissory notes: a $150 million unsecured note and a $75 million secured note.
Impairment charge expected, but the company cannot yet estimate its full amount or range; it will disclose an estimate in an amended 8-K.
Marcio A. Sandri remains President, Composites, but no longer serves as an executive officer, effective February 13, 2025.
Essent Group reported fourth-quarter 2024 net income of $167.9 million, or $1.58 per diluted share, down from $175.4 million, or $1.64, a year earlier. For full-year 2024, net income rose to $729.4 million, or $6.85 per diluted share, from $696.4 million, or $6.50, in 2023, and the board declared a $0.31 quarterly dividend and approved a $500 million share repurchase authorization.
Q4 2024 total revenues were $315.0 million, up from $297.3 million in Q4 2023, while Q4 net income declined.
Full-year 2024 net income was $729.4 million, or $6.85 per diluted share, versus $696.4 million, or $6.50, in 2023.
Quarterly cash dividend of $0.31 per common share is payable March 24, 2025, to holders of record on March 14, 2025.
In February 2025 the board approved a $500 million share repurchase authorization that runs through year-end 2026.
Moderna reported fourth-quarter 2024 revenue of $1.0 billion, down from $2.8 billion a year earlier, and a net loss of $1.1 billion, compared with net income of $217 million in the same quarter of 2023. For the full year, revenue fell to $3.2 billion from $6.8 billion, but the net loss narrowed to $3.6 billion from $4.7 billion, and the company reiterated its 2025 revenue range of $1.5 to $2.5 billion.
Q4 2024 net loss was $1.1 billion, or $(2.91) per share, versus Q4 2023 net income of $217 million
Q4 2024 cost of sales included a non-cash charge of $238 million tied to termination of a contract manufacturing agreement
Full-year 2024 revenue was $3.2 billion versus $6.8 billion in 2023; net loss was $3.6 billion versus $4.7 billion
2025 revenue expected at $1.5 to $2.5 billion (reiterated), with year-end 2025 cash and investments projected at approximately $6 billion
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.